Nephros, Inc.
NEPH
$4.36
$0.307.39%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 30.82% | -3.12% | 1,513.51% | 259.42% | 202.55% |
| Total Depreciation and Amortization | -13.99% | -10.49% | 2.92% | -5.88% | -18.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -16.21% | 2.36% | 5.52% | -18.38% | -20.59% |
| Change in Net Operating Assets | -586.97% | -64.39% | 62.16% | 104.00% | 51.48% |
| Cash from Operations | -133.10% | -169.32% | 434.35% | 233.74% | 335.50% |
| Capital Expenditure | -- | -- | -- | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -100.00% | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 100.00% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -100.00% | -25.00% | 0.00% | 28.57% | 57.14% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 9,566.67% | 7,225.00% | 0.00% | 28.57% | 57.14% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -118.91% | -114.06% | 399.82% | 225.36% | 303.47% |